Ductal adenocarcinoma of the prostate gland - Revision history

Michael: fix image

2019-02-19T14:46:12Z

fix image

← Older revision		Revision as of 14:46, 19 February 2019
Line 9:		Line 9:
	\| LMDDx = [[acinar adenocarcinoma of prostate]], [[prostatic-type polyp]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]]		\| LMDDx = [[acinar adenocarcinoma of prostate]], [[prostatic-type polyp]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]]
	\| Stains =		\| Stains =
	\| IHC = chromogranin A +ve, p53 +ve, PSA +ve		\| IHC = chromogranin A +ve, p53 +ve, PSA +ve
	\| EM =		\| EM =
	\| Molecular =		\| Molecular =

Michael: /* IHC */ +so section

2017-10-22T12:54:12Z

IHC: +so section

← Older revision		Revision as of 12:54, 22 October 2017
Line 90:		Line 90:
	Others:<ref name=pmid20368883>{{Cite journal \| last1 = Kumar \| first1 = A. \| last2 = Mukherjee \| first2 = SD. \| title = Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment. \| journal = Can Urol Assoc J \| volume = 4 \| issue = 2 \| pages = E50-4 \| month = Apr \| year = 2010 \| doi = \| PMID = 20368883 }}</ref>		Others:<ref name=pmid20368883>{{Cite journal \| last1 = Kumar \| first1 = A. \| last2 = Mukherjee \| first2 = SD. \| title = Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment. \| journal = Can Urol Assoc J \| volume = 4 \| issue = 2 \| pages = E50-4 \| month = Apr \| year = 2010 \| doi = \| PMID = 20368883 }}</ref>
	*PSA +ve.		*PSA +ve.

			==Sign out==
			===Comment about small amount of ductal adenocarcinoma===
			<pre>
			A small amount of ductal-type adenocarcinoma of the prostate is seen; it represents approximately 5% of the tumour by volume and is of no particular prognostic significance. As the volume of the ductal-type adenocarcinoma is small, the case is classified as acinar adenocarcinoma.
			</pre>

	==See also==		==See also==

Michael: /* Microscopic */

2017-03-06T03:19:07Z

Microscopic

← Older revision		Revision as of 03:19, 6 March 2017
Line 64:		Line 64:
	*[[Prostatic-type polyp]] - benign uncommon pathology, typically present with hematuria.		*[[Prostatic-type polyp]] - benign uncommon pathology, typically present with hematuria.
	*[[Adenocarcinoma of the urinary bladder]].		*[[Adenocarcinoma of the urinary bladder]].
			*[[PIN-like adenocarcinoma]] - does not have papillary architecture.
	*Metastatic [[adenocarcinoma]].		*Metastatic [[adenocarcinoma]].

Michael at 20:03, 30 December 2016

2016-12-30T20:03:14Z

← Older revision		Revision as of 20:03, 30 December 2016
Line 7:		Line 7:
	\| Micro =		\| Micro =
	\| Subtypes = (subtype of [[prostate carcinoma]])		\| Subtypes = (subtype of [[prostate carcinoma]])
	\| LMDDx = [[acinar adenocarcinoma of prostate]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]]		\| LMDDx = [[acinar adenocarcinoma of prostate]], [[prostatic-type polyp]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]]
	\| Stains =		\| Stains =
	\| IHC = chromogranin A +ve, p53 +ve, PSA +ve		\| IHC = chromogranin A +ve, p53 +ve, PSA +ve

Michael: /* Microscopic */

2016-12-30T20:00:57Z

Microscopic

← Older revision		Revision as of 20:00, 30 December 2016
Line 62:		Line 62:
	DDx:		DDx:
	*[[Acinar adenocarcinoma of prostate]] - main DDx.		*[[Acinar adenocarcinoma of prostate]] - main DDx.
			*[[Prostatic-type polyp]] - benign uncommon pathology, typically present with hematuria.
	*[[Adenocarcinoma of the urinary bladder]].		*[[Adenocarcinoma of the urinary bladder]].
	*Metastatic [[adenocarcinoma]].		*Metastatic [[adenocarcinoma]].

Michael at 03:21, 9 February 2016

2016-02-09T03:21:22Z

← Older revision		Revision as of 03:21, 9 February 2016
Line 16:		Line 16:
	\| Grossing = [[prostate biopsy]], [[prostate chips]], [[radical prostatectomy]]		\| Grossing = [[prostate biopsy]], [[prostate chips]], [[radical prostatectomy]]
	\| Staging = [[prostate cancer staging]]		\| Staging = [[prostate cancer staging]]
	\| Site = [[prostate gland]] - central zone		\| Site = [[prostate gland]] - esp. central zone, see ''[[prostate cancer]]''
	\| Assdx =		\| Assdx =
	\| Syndromes =		\| Syndromes =

Michael at 03:18, 9 February 2016

2016-02-09T03:18:12Z

← Older revision		Revision as of 03:18, 9 February 2016
Line 1:		Line 1:
	{{ Infobox diagnosis		{{ Infobox diagnosis
	\| Name = {{PAGENAME}}		\| Name = {{PAGENAME}}
	\| Image =		\| Image = Ductal adenocarcinoma of prostate -- intermed mag.jpg
	\| Width =		\| Width =
	\| Caption =		\| Caption = Ductal adenocarcinoma of prostate. [[H&E stain]]. (WC)
	\| Synonyms = prostatic ductal adenocarcinoma, endometrioid adenocarcinoma (use discouraged), papillary adenocarcinoma of prostate (old term)		\| Synonyms = prostatic ductal adenocarcinoma, endometrioid adenocarcinoma (use discouraged), papillary adenocarcinoma of prostate (old term)
	\| Micro =		\| Micro =
Line 66:		Line 66:

	===Images===		===Images===
	www:		<gallery>
			Image: Ductal adenocarcinoma of prostate -- low mag.jpg \| DAP - low mag.
			Image: Ductal adenocarcinoma of prostate -- intermed mag.jpg \| DAP - intermed. mag.
			Image: Ductal adenocarcinoma of prostate -- high mag.jpg \| DAP - high mag.
			Image: Ductal adenocarcinoma of prostate -- very high mag.jpg \| DAP - very high mag.
			</gallery>
			====www====
	*[http://path.upmc.edu/cases/case203.html Prostatic ductal adenocarcinoma - several images (upmc.edu)].		*[http://path.upmc.edu/cases/case203.html Prostatic ductal adenocarcinoma - several images (upmc.edu)].
	*[http://path.upmc.edu/cases/case711.html Prostatic ductal adenocarcinoma - another case - several images (upmc.edu)].		*[http://path.upmc.edu/cases/case711.html Prostatic ductal adenocarcinoma - another case - several images (upmc.edu)].

Michael at 03:15, 9 February 2016

2016-02-09T03:15:31Z

← Older revision		Revision as of 03:15, 9 February 2016
Line 7:		Line 7:
	\| Micro =		\| Micro =
	\| Subtypes = (subtype of [[prostate carcinoma]])		\| Subtypes = (subtype of [[prostate carcinoma]])
	\| LMDDx = [[acinar adenocarcinoma]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]]		\| LMDDx = [[acinar adenocarcinoma of prostate]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]]
	\| Stains =		\| Stains =
	\| IHC = chromogranin A +ve, p53 +ve, PSA +ve		\| IHC = chromogranin A +ve, p53 +ve, PSA +ve
Line 59:		Line 59:
	**<10% ductal component of no prognostic significance.<ref name=pmid21383610>{{Cite journal \| last1 = Amin \| first1 = A. \| last2 = Epstein \| first2 = JI. \| title = Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma. \| journal = Am J Surg Pathol \| volume = 35 \| issue = 4 \| pages = 615-9 \| month = Apr \| year = 2011 \| doi = 10.1097/PAS.0b013e31820eb25b \| PMID = 21383610 }}</ref>		**<10% ductal component of no prognostic significance.<ref name=pmid21383610>{{Cite journal \| last1 = Amin \| first1 = A. \| last2 = Epstein \| first2 = JI. \| title = Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma. \| journal = Am J Surg Pathol \| volume = 35 \| issue = 4 \| pages = 615-9 \| month = Apr \| year = 2011 \| doi = 10.1097/PAS.0b013e31820eb25b \| PMID = 21383610 }}</ref>
	*‡‡ ''Mahul Amin'' advocates that >=80% should be ductal morphology to call ''ductal adenocarcinoma''.<ref>{{Ref Amin\|3-102}}</ref>		*‡‡ ''Mahul Amin'' advocates that >=80% should be ductal morphology to call ''ductal adenocarcinoma''.<ref>{{Ref Amin\|3-102}}</ref>

			DDx:
			*[[Acinar adenocarcinoma of prostate]] - main DDx.
			*[[Adenocarcinoma of the urinary bladder]].
			*Metastatic [[adenocarcinoma]].

	===Images===		===Images===
	www:		www:

Michael: +infobox

2016-02-09T03:14:11Z

+infobox

← Older revision		Revision as of 03:14, 9 February 2016
Line 1:		Line 1:
			{{ Infobox diagnosis
			\| Name = {{PAGENAME}}
			\| Image =
			\| Width =
			\| Caption =
			\| Synonyms = prostatic ductal adenocarcinoma, endometrioid adenocarcinoma (use discouraged), papillary adenocarcinoma of prostate (old term)
			\| Micro =
			\| Subtypes = (subtype of [[prostate carcinoma]])
			\| LMDDx = [[acinar adenocarcinoma]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]]
			\| Stains =
			\| IHC = chromogranin A +ve, p53 +ve, PSA +ve
			\| EM =
			\| Molecular =
			\| IF =
			\| Gross =
			\| Grossing = [[prostate biopsy]], [[prostate chips]], [[radical prostatectomy]]
			\| Staging = [[prostate cancer staging]]
			\| Site = [[prostate gland]] - central zone
			\| Assdx =
			\| Syndromes =
			\| Clinicalhx =
			\| Signs =
			\| Symptoms =
			\| Prevalence = uncommon - though considered most common non-acinar prostate carcinoma
			\| Bloodwork =
			\| Rads =
			\| Endoscopy =
			\| Prognosis = poor
			\| Other =
			\| ClinDDx =
			\| Tx =
			}}
	'''Ductal adenocarcinoma of the prostate gland''', also '''prostatic ductal adenocarcinoma''', is relatively common variant of [[prostate cancer]].		'''Ductal adenocarcinoma of the prostate gland''', also '''prostatic ductal adenocarcinoma''', is relatively common variant of [[prostate cancer]].

Michael at 03:03, 9 February 2016

2016-02-09T03:03:21Z

← Older revision		Revision as of 03:03, 9 February 2016
Line 2:		Line 2:

	It is also known as '''prostatic adenocarcinoma, large duct type'''.		It is also known as '''prostatic adenocarcinoma, large duct type'''.

			It should '''not''' be confused with ''[[intraductal carcinoma of the prostate gland]]''.

	==General==		==General==
	*Sometimes it is referred to as ''endometrioid'' or ''endometrial'' adenocarcinoma; both terms are discouraged.<ref name=pmid18773743>{{Cite journal \| last1 = Samaratunga \| first1 = H. \| last2 = Delahunt \| first2 = B. \| title = Ductal adenocarcinoma of the prostate: current opinion and controversies. \| journal = Anal Quant Cytol Histol \| volume = 30 \| issue = 4 \| pages = 237-46 \| month = Aug \| year = 2008 \| doi = \| PMID = 18773743 }}</ref>		*Sometimes it is referred to as ''endometrioid'' or ''endometrial'' adenocarcinoma; both terms are discouraged.<ref name=pmid18773743>{{Cite journal \| last1 = Samaratunga \| first1 = H. \| last2 = Delahunt \| first2 = B. \| title = Ductal adenocarcinoma of the prostate: current opinion and controversies. \| journal = Anal Quant Cytol Histol \| volume = 30 \| issue = 4 \| pages = 237-46 \| month = Aug \| year = 2008 \| doi = \| PMID = 18773743 }}</ref>
Line 44:		Line 47:
	==See also==		==See also==
	*[[Prostate cancer]].		*[[Prostate cancer]].
			*[[Ductal adenocarcinoma]].
			*[[Intraductal carcinoma of the prostate gland]].

	==References==		==References==